Nothing Special   »   [go: up one dir, main page]

BRPI0912727A8 - Marcadores genéticos para controle de peso e métodos e uso dos mesmos - Google Patents

Marcadores genéticos para controle de peso e métodos e uso dos mesmos

Info

Publication number
BRPI0912727A8
BRPI0912727A8 BRPI0912727A BRPI0912727A BRPI0912727A8 BR PI0912727 A8 BRPI0912727 A8 BR PI0912727A8 BR PI0912727 A BRPI0912727 A BR PI0912727A BR PI0912727 A BRPI0912727 A BR PI0912727A BR PI0912727 A8 BRPI0912727 A8 BR PI0912727A8
Authority
BR
Brazil
Prior art keywords
methods
individual
weight loss
genetic markers
weight
Prior art date
Application number
BRPI0912727A
Other languages
English (en)
Inventor
Draper Colleen
Wilkins Leon
Breton Gary
Perusse Louis
Debusk Ruth
Ramakrishnan Shyam
W Klempin David
Original Assignee
Interleulkin Genetics Inc
Alticor Inc
Access Business Group Int Llc
Orig3N Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interleulkin Genetics Inc, Alticor Inc, Access Business Group Int Llc, Orig3N Inc filed Critical Interleulkin Genetics Inc
Publication of BRPI0912727A2 publication Critical patent/BRPI0912727A2/pt
Publication of BRPI0912727A8 publication Critical patent/BRPI0912727A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/60—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

MARCADORES GENÉTICOS PARA CONTROLE DE PESO E MÉTODOS E USO DOS MESMOS. Este pedido diz respeito a métodos e testes que permitem o estabelecimento de programas de perda de peso personalizados para um indivíduo com base no genótipo metabólico do indivíduo em genes metabólicos chaves. São revelados kits e métodos para determinar um genótipo metabólico do indivíduo, que podem ser usados para selecionar um regime terapêutico/dietário apropriado ou recomendação de estilo de vida com base na probabilidade de respostas de um indivíduo a certos níveis de dietas e atividade. Um programa de perda de peso personalizado como esse terá benefícios óbvios (por exemplo, resulta em melhor rendimento em termos de perda de peso e manutenção de peso) em programas de perda de peso tradicionais que não levam em conta informação genética.
BRPI0912727A 2008-05-16 2009-05-15 Marcadores genéticos para controle de peso e métodos e uso dos mesmos BRPI0912727A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5388808P 2008-05-16 2008-05-16
PCT/US2009/044076 WO2009140569A2 (en) 2008-05-16 2009-05-15 Genetic markers for weight management and methods of use thereof

Publications (2)

Publication Number Publication Date
BRPI0912727A2 BRPI0912727A2 (pt) 2017-08-29
BRPI0912727A8 true BRPI0912727A8 (pt) 2017-10-03

Family

ID=41134677

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0912727A BRPI0912727A8 (pt) 2008-05-16 2009-05-15 Marcadores genéticos para controle de peso e métodos e uso dos mesmos

Country Status (16)

Country Link
US (2) US20100105038A1 (pt)
EP (2) EP2291543B1 (pt)
JP (1) JP5651585B2 (pt)
KR (1) KR101668122B1 (pt)
CN (2) CN102099487B (pt)
AU (1) AU2009246199C1 (pt)
BR (1) BRPI0912727A8 (pt)
CA (2) CA2724497C (pt)
DK (1) DK2291543T3 (pt)
EA (1) EA018875B1 (pt)
ES (1) ES2539825T3 (pt)
HK (3) HK1158703A1 (pt)
MX (1) MX2010012371A (pt)
NZ (1) NZ589863A (pt)
PL (1) PL2291543T3 (pt)
WO (2) WO2009140601A2 (pt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100136561A1 (en) * 2008-05-16 2010-06-03 Interleukin Genetics, Inc. Genetic Markers for Weight Management and Methods of Use Thereof
DK2291543T3 (en) * 2008-05-16 2015-06-01 Interleukin Genetics Inc GENETIC MARKERS FOR WEIGHT CONTROL AND methods of use thereof
US20120258183A1 (en) * 2009-10-16 2012-10-11 Graeme John Smith Macronutrient sensitivity
US9554754B2 (en) * 2010-01-08 2017-01-31 Jeffrey Ruby System, method and computer program for weight, lifestyle and/or disease management integrating nutrition, exercise and behaviour management
US20130053270A1 (en) * 2010-02-24 2013-02-28 Bodysync, Inc. Methods for determining gene-nutrient interactions
JP2012000081A (ja) * 2010-06-21 2012-01-05 Haplo Pharma:Kk Ｓｎｐによる肥満化のリスクの予測
US20130138447A1 (en) * 2010-07-19 2013-05-30 Pathway Genomics Genetic based health management apparatus and methods
US8762167B2 (en) * 2010-07-27 2014-06-24 Segterra Inc. Methods and systems for generation of personalized health plans
CN102676639A (zh) * 2011-03-08 2012-09-19 重庆卡农科技有限公司 一种用于制定个体化减重方案的分子标记试剂盒
US20120295256A1 (en) * 2011-05-18 2012-11-22 Genovive Llc Weight management genetic test systems and methods
WO2013043554A1 (en) 2011-09-23 2013-03-28 Access Business Group International Llc Methods for creating recommended dietary regime
JP2013097693A (ja) * 2011-11-04 2013-05-20 Hitachi Solutions Ltd 骨粗鬆症リスク判定システム及びプログラム
WO2014026263A1 (en) * 2012-08-17 2014-02-20 Braghetto Neto Jose Virgilio Genetic-based e-commerce systems and methods
WO2014047388A1 (en) 2012-09-21 2014-03-27 Ethicon Endo-Surgery, Inc. Systems and methods for predicting metabolic and bariatric surgery outcomes
EP2898101A4 (en) 2012-09-21 2016-08-03 Ethicon Endo Surgery Inc CLINICAL PREDICTORS FOR WEIGHT LOSS
US10242756B2 (en) 2012-09-21 2019-03-26 Ethicon Endo-Surgery, Inc. Systems and methods for predicting metabolic and bariatric surgery outcomes
CN102912452A (zh) * 2012-09-28 2013-02-06 湖北维达健基因技术有限公司 一种用于体重控制的基因芯片、制备方法、使用方法及其试剂盒
CN103678874B (zh) * 2013-10-14 2016-06-29 冯力新 一种个人健康膳食与运动能量平衡管理方法
CN103834739A (zh) * 2014-03-13 2014-06-04 上海中优门诊部有限公司 一种脂质代谢型肥胖基因体质评估的方法
WO2016049917A1 (en) * 2014-09-30 2016-04-07 Bgi Shenzhen Co., Limited Biomarkers for obesity related diseases
WO2016049927A1 (en) * 2014-09-30 2016-04-07 Bgi Shenzhen Co., Limited Biomarkers for obesity related diseases
CN105586395A (zh) * 2014-11-17 2016-05-18 武汉白原科技有限公司 一种人体对日常饮食反应的检测试剂盒和方法
CN105671138A (zh) * 2014-11-18 2016-06-15 武汉白原科技有限公司 一种饮食对肥胖影响的检测试剂盒和方法
CN105132566A (zh) * 2015-09-21 2015-12-09 上海中优生物高科技有限责任公司 毒素堆积型肥胖基因个体化干预饮品的制备方法及其系统
EP3402900A1 (en) 2016-01-12 2018-11-21 Interleukin Genetics, Inc. Methods for predicting response to treatment
CN105821136A (zh) * 2016-04-29 2016-08-03 上海弥健生物科技有限公司 个性化基因分型指导健身减肥的方法及其设备应用
CN107252088A (zh) * 2016-08-26 2017-10-17 云健康基因科技（上海）有限公司 一种用于脂类代谢异常型肥胖症的食品的制备方法
WO2018081175A1 (en) 2016-10-24 2018-05-03 Habit, Llc System and method for implementing meal selection based on vitals, genotype, and phenotype
US10329620B2 (en) 2017-01-12 2019-06-25 Cardioforecast Ltd. Methods and kits for treating cardiovascular disease
CN110494880A (zh) * 2017-01-27 2019-11-22 欧瑞3恩公司 基于个人基因轮廓来判定和展现购买建议的系统和方法
RU2691145C2 (ru) * 2017-10-09 2019-06-11 Общество с ограниченной ответственностью "Национальный центр генетических исследований" Способ формирования индивидуальных диетических рекомендаций на основе ДНК анализа
US11322255B2 (en) 2019-04-04 2022-05-03 Kpn Innovations, Llc. Methods and systems for self-fulfillment of an alimentary instruction set based on vibrant constitutional guidance
US11222727B2 (en) 2019-04-04 2022-01-11 Kpn Innovations, Llc Systems and methods for generating alimentary instruction sets based on vibrant constitutional guidance
US10553316B1 (en) 2019-04-04 2020-02-04 Kpn Innovations, Llc Systems and methods for generating alimentary instruction sets based on vibrant constitutional guidance
US11315684B2 (en) 2019-04-04 2022-04-26 Kpn Innovations, Llc. Systems and methods for generating alimentary instruction sets based on vibrant constitutional guidance
US12040090B2 (en) 2019-04-04 2024-07-16 Kpn Innovations, Llc. Systems and methods for generating alimentary instruction sets based on vibrant constitutional guidance
EP3980561A1 (en) 2019-06-06 2022-04-13 Sitokine Limited Compositions and methods for treating lung, colorectal and breast cancer
WO2021028469A1 (en) 2019-08-12 2021-02-18 Sitokine Limited Compositions and methods for treating cytokine release syndrome and neurotoxicity
WO2021205013A1 (en) 2020-04-09 2021-10-14 Sitokine Limited Compositions and methods for treating covid-19
US11594316B2 (en) 2020-05-04 2023-02-28 Kpn Innovations, Llc. Methods and systems for nutritional recommendation using artificial intelligence analysis of immune impacts
US11875889B2 (en) 2020-05-29 2024-01-16 Kpn Innovations, Llc. Methods and systems of alimentary provisioning
US12009085B2 (en) 2020-07-27 2024-06-11 Kpn Innovations, Llc. Systems and methods for scheduling alimentary combinations
US11393572B2 (en) 2020-11-03 2022-07-19 Kpn Innovations, Llc. System and method for modifying a nutrition requirement
US11145401B1 (en) 2020-12-29 2021-10-12 Kpn Innovations, Llc. Systems and methods for generating a sustenance plan for managing genetic disorders
US20230170073A1 (en) 2022-03-04 2023-06-01 Mohsin Mehdi Automated personalized nutrition and lifestyle recommendation system and associated method thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311018D0 (en) 1983-04-22 1983-05-25 Amersham Int Plc Detecting mutations in dna
US4998617A (en) 1986-09-15 1991-03-12 Laura Lupton Inc Facial cosmetic liquid make up kit
US5459039A (en) * 1989-05-12 1995-10-17 Duke University Methods for mapping genetic mutations
FR2650840B1 (fr) 1989-08-11 1991-11-29 Bertin & Cie Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications
US6004744A (en) 1991-03-05 1999-12-21 Molecular Tool, Inc. Method for determining nucleotide identity through extension of immobilized primer
ATE267877T1 (de) 1993-01-07 2004-06-15 Sequenom Inc Dns - sequenzierung durch massenspektronomie
US5593826A (en) * 1993-03-22 1997-01-14 Perkin-Elmer Corporation, Applied Biosystems, Inc. Enzymatic ligation of 3'amino-substituted oligonucleotides
US20030092019A1 (en) * 2001-01-09 2003-05-15 Millennium Pharmaceuticals, Inc. Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
US20030091687A1 (en) * 2001-11-13 2003-05-15 Copelan James Bradford Healthy diet system
US20030204412A1 (en) * 2002-04-29 2003-10-30 John Brier Apparatus and method for providing on-line customized nutrition, fitness, and lifestyle plans based upon a user profile and goals
JP2004105145A (ja) * 2002-09-20 2004-04-08 Japan Science & Technology Corp 心血管疾患、肥満および生活習慣病の遺伝的リスクを簡便に判定する方法
KR101177138B1 (ko) * 2003-09-12 2012-08-24 인터레우킨 제네틱스, 인코포레이티드 건강 상태를 조절하기 위한 프로그램
US20050191678A1 (en) * 2004-02-12 2005-09-01 Geneob Usa Inc. Genetic predictability for acquiring a disease or condition
JP2006067866A (ja) * 2004-09-01 2006-03-16 Toshihide Yoshida 肥満関連遺伝子及びその利用
US20060252050A1 (en) * 2005-05-06 2006-11-09 Ordovas Jose M Genetic marker for weight regulation
US20090222282A1 (en) * 2005-09-15 2009-09-03 Trustees Of Tufts College Method for Personalized Diet Design
WO2007044470A2 (en) * 2005-10-05 2007-04-19 Trustees Of Tufts College Method for personalized diet design for females of asian origin
US20070111217A1 (en) * 2005-11-14 2007-05-17 Julieta Uthurralt Quantitative trait locus prognostic for changes in regional adiposity and BMI in Caucasian males
US20070196841A1 (en) * 2006-01-20 2007-08-23 Gualberto Ruano Physiogenomic method for predicting response to diet
JP5686333B2 (ja) * 2006-02-02 2015-03-18 Ｇ＆Ｇサイエンス株式会社 心筋梗塞の遺伝的リスク検出法
US20070218107A1 (en) * 2006-03-14 2007-09-20 Schnur Steven A Method of dieting and tools for implementing same
US20080171335A1 (en) * 2006-11-30 2008-07-17 Trustees Of Tufts College Method for personalized diet design
DK2291543T3 (en) * 2008-05-16 2015-06-01 Interleukin Genetics Inc GENETIC MARKERS FOR WEIGHT CONTROL AND methods of use thereof
US20100136561A1 (en) * 2008-05-16 2010-06-03 Interleukin Genetics, Inc. Genetic Markers for Weight Management and Methods of Use Thereof

Also Published As

Publication number Publication date
HK1217972A1 (zh) 2017-01-27
CN102099487B (zh) 2015-08-26
PL2291543T3 (pl) 2015-09-30
AU2009246199C1 (en) 2016-08-11
CA2724497A1 (en) 2009-11-19
AU2009246199A1 (en) 2009-11-19
KR20110018909A (ko) 2011-02-24
CA3015564C (en) 2020-06-02
BRPI0912727A2 (pt) 2017-08-29
KR101668122B1 (ko) 2016-10-20
US20100098809A1 (en) 2010-04-22
US20100105038A1 (en) 2010-04-29
CN105154525B (zh) 2019-09-17
JP2011520453A (ja) 2011-07-21
CN102099487A (zh) 2011-06-15
MX2010012371A (es) 2011-05-23
EA018875B1 (ru) 2013-11-29
ES2539825T3 (es) 2015-07-06
EP2947159A1 (en) 2015-11-25
EP2291543B1 (en) 2015-04-15
WO2009140601A3 (en) 2010-04-08
NZ589863A (en) 2012-11-30
AU2009246199B2 (en) 2016-03-03
WO2009140569A3 (en) 2010-01-14
JP5651585B2 (ja) 2015-01-14
DK2291543T3 (en) 2015-06-01
EA201071319A1 (ru) 2011-06-30
CA2724497C (en) 2018-10-09
CA3015564A1 (en) 2009-11-19
HK1158703A1 (zh) 2012-07-20
HK1218937A1 (zh) 2017-03-17
WO2009140601A2 (en) 2009-11-19
EP2291543A2 (en) 2011-03-09
CN105154525A (zh) 2015-12-16
WO2009140569A2 (en) 2009-11-19

Similar Documents

Publication Publication Date Title
BRPI0912727A8 (pt) Marcadores genéticos para controle de peso e métodos e uso dos mesmos
Matthews et al. Novelty‐seeking DRD4 polymorphisms are associated with human migration distance out‐of‐Africa after controlling for neutral population gene structure
WO2010048378A3 (en) Genetic markers for weight management and methods of use thereof
Sun et al. ACF chromatin-remodeling complex mediates stress-induced depressive-like behavior
Zhao et al. Mitochondrial dynamics regulates migration and invasion of breast cancer cells
Youngblood et al. Identification and functional assessment of the novel murine organic anion transporter Oat5 (Slc22a19) expressed in kidney
Fox et al. Differential sensitivity to the environment: contribution of cognitive biases and genes to psychological wellbeing
Choi et al. Epigenetic regulation and the variability of gene expression
WO2011063098A3 (en) Genetic markers for weight management and methods of use thereof
Cheng et al. LncRNA UCA1 enhances cisplatin resistance by regulating CYP1B1-mediated apoptosis via miR-513a-3p in human gastric cancer
ATE535807T1 (de) Gensignaturen
IN2014DN04226A (pt)
Wang et al. The role of peroxiredoxin II in chemoresistance of breast cancer cells
Peshenko et al. Dimerization domain of retinal membrane guanylyl cyclase 1 (RetGC1) is an essential part of guanylyl cyclase-activating protein (GCAP) binding interface
BR112012005670A2 (pt) ''método para a identificação de um paciente com câncer que pode se beneficiar com a terapia antiagiogênica, método para a predição da responsividade de um paciente com câncer à terapia antiangiogênica, uso de um anticorpo anto- vegf para melhorar o efeito do tratamento de um paciente sofrendo de câncer, método ou uso, kit útil para realizar o método, uso de uma proteína ou usom kit útil para realizar o método, uso de uma proteína ou oligonucleotídeo ou matriz de polinecleotídeo para determinar o nível de expressão de bfgf em um método e kit ou uso
BRPI0608429A2 (pt) método e kit para prognóstico ou avaliação da eficácia do tratamento de um tumor sólido em um paciente de interesse; e método para a identificação de marcadores que sejam prognósticos de um tumor sólido
Morris et al. The association of spinophilin with disks large-associated protein 3 (SAPAP3) is regulated by metabotropic glutamate receptor (mGluR) 5
Perrine et al. Cocaine regulates protein kinase B and glycogen synthase kinase‐3 activity in selective regions of rat brain
Dewar et al. Mistargeting of aggregation prone mitochondrial proteins activates a nucleus-mediated posttranscriptional quality control pathway in trypanosomes
BR112021005774A2 (pt) ensaios de neurotoxina de clostridiana à base de célula
Mah et al. Novel SNP improves differential survivability and mortality in non-small cell lung cancer patients
Haoula et al. Validation of proteomic biomarkers previously found to be differentially expressed in women with polycystic ovary syndrome: a cross-sectional study
Halls et al. Signal switching after stimulation of LGR7 receptors by human relaxin 2
Haniu et al. DJ-1 as a potential biomarker for the development of biocompatible multiwalled carbon nanotubes
Pollak et al. Strain‐dependent regulation of neurotransmission and actin‐remodelling proteins in the mouse hippocampus

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: INTERLEULKIN GENETICS, INC. (US) , ACCESS BUSINESS

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25A Requested transfer of rights approved

Owner name: ACCESS BUSINESS GROUP INTERNATIONAL LLC (US) ; ORI

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements